🍂 Enjoy the Fall Season! 🍂
MindTheDesk

Big pharma companies Moderna and Merck push new mRNA cancer vaccine to prevent melanoma recurrence

News Archived • August 21, 2026 • 2 views
According to two U.S.-based pharmaceutical companies, a phase 3 clinical trial has allegedly shown that a personalized mRNA cancer vaccine improves outcomes when added to standard immunotherapy in patients with high-risk melanoma.
Source: OANN | https://www.oann.com/feed/ - Read Original
"Monetize your website or boost your business with Code-Oryx. Join the network today!"
"Output is a realization of Input."

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!

Sponsored
"Network Cable Repairs from $29"